Clinical Trial Update: Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating safety, efficacy, and pharmacodynamics of FE203799 in adults with Short Bowel Syndrome on parenteral support; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• FE203799

Snippet

Sponsor: GlyPharma Therapeutics | Conditions: Short Bowel Syndrome | Phase 1, Phase 2 | Status: COMPLETED